Abstract-Previous studies suggest that neuronal norepinephrine transporter function may regulate the distribution of sympathetic activity among blood vessels, heart, and kidney; we tested the functional relevance in humans. Sixteen healthy men (26Ϯ1 years) ingested 8 mg of the selective norepinephrine reuptake transporter inhibitor reboxetine or a matching placebo on 2 separate days in a double-blind, randomized, crossover fashion. We monitored heart rate, thoracic bioimpedance, blood pressure, glomerular filtration rate, and renal blood flow. Ninety minutes after ingestion of the test medication, subjects were tilted to a 45°head-up position, where they remained for an additional 30 minutes. Reboxetine increased supine systolic blood pressure through an increase in cardiac output whereas systemic vascular resistance decreased. Furthermore, reboxetine increased heart rate, particularly with a head-up tilt. Supine plasma renin activity was 0.71Ϯ0.15 ng angiotensin (Ang)/L per mL/h with placebo and 0.36Ϯ0.07 ngAng/L per mL/h with reboxetine (PϽ0.01). Supine plasma Ang II concentrations were also decreased with reboxetine. Both plasma renin activity and Ang II concentrations remained suppressed during head-up tilt. On placebo, renal vascular resistance increased with head-up tilt. The response was abolished with norepinephrine reuptake inhibition. We conclude that norepinephrine reuptake function profoundly influences the distribution of sympathetic activity between the heart, vasculature, and kidney in humans. All of these changes are physiologically relevant because they lead to corresponding changes in organ function. (Hypertension. 2006;48:120-126.)Key Words: sympathetic nervous system Ⅲ norepinephrine Ⅲ renal circulation Ⅲ renin-angiotensin system S ympathetic activity is not evenly distributed among the blood vessels, heart, and kidney. Discordant sympathetic activation of the heart and the kidney may be relevant to common cardiovascular disorders. For example, the postural tachycardia syndrome (POTS) is associated with excessive cardiac sympathetic activity. 1 Decreased renal sympathetic activity in POTS is suggested by hypovolemia together with inappropriately low renin-angiotensin system activity. 2 In contrast, in obese subjects, renal norepinephrine spillover is increased. 3 Sympathetic traffic to the vasculature may also be increased, at least in a subgroup of obese patients. 4,5 Cardiac sympathetic activity is suppressed in obese normotensive persons and is within the normal range in obese hypertensive patients. 6 Yet, the mechanisms regulating sympathetic distribution between the heart and kidney are poorly understood. Norepinephrine reuptake transporter (NET) function may be important in this regard. Acute pharmacological NET blockade reduces sympathetic vasomotor tone 7 and renal norepinephrine spillover in humans. 8 In contrast, cardiac norepinephrine spillover 8 and upright heart rate are substantially increased. 9 Similarly, upright heart rate is increased in patients with genetic NET deficiency....